Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.6 USD | -3.45% | -0.63% | -20.65% |
Apr. 25 | Top Premarket Gainers | MT |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
Financials (USD)
Sales 2024 * | 24.07M | Sales 2025 * | 42.86M | Capitalization | 59.53M |
---|---|---|---|---|---|
Net income 2024 * | -61M | Net income 2025 * | -40M | EV / Sales 2024 * | 2.47 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.39 x |
P/E ratio 2024 * |
-0.98
x | P/E ratio 2025 * |
-2.3
x | Employees | 69 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.66% |
Latest transcript on Cidara Therapeutics, Inc.
1 day | -3.45% | ||
1 week | -0.63% | ||
Current month | +5.18% | ||
1 month | -28.00% | ||
3 months | -13.46% | ||
6 months | -16.33% | ||
Current year | -20.65% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Preetam Shah
DFI | Director of Finance/CFO | 51 | 21-08-31 |
Les Tari
CTO | Chief Tech/Sci/R&D Officer | 57 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Burgess
CHM | Chairman | 62 | 14-03-31 |
Director/Board Member | 69 | 14-03-31 | |
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 12.6 | -3.45% | 27,810 |
24-05-08 | 13.05 | -2.90% | 17,270 |
24-05-07 | 13.44 | -1.25% | 40,727 |
24-05-06 | 13.61 | +8.79% | 102,155 |
24-05-03 | 12.51 | -1.34% | 54,051 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.65% | 57.48M | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.85% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- CDTX Stock